PANCREATIC CANCER NON-RESECTABLE
Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can digestive enzymes help pancreatic cancer patients keep weight on?
Disease control OngoingThis study tests whether taking pancreatic enzymes (Pertzye) with meals can help people with metastatic pancreatic cancer maintain their body weight during chemotherapy. The trial includes 17 participants who are starting a standard chemo regimen called FOLFIRINOX. Researchers wi…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo therapy targets tough pancreatic cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called nimotuzumab combined with radiation and chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this combination can better control the tumor for at least a year. The trial will enroll 30 part…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New study compares two drainage techniques to ease jaundice in advanced cancer patients
Symptom relief TerminatedThis study compares two minimally invasive procedures to drain blocked bile ducts in patients with incurable cancer. One method drains the bile duct into the intestine, the other drains the gallbladder into the stomach. The goal is to see which approach causes fewer complications…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to predict best pancreatic cancer therapy
Knowledge-focused OngoingThis observational study of 70 pancreatic cancer patients aims to build a model that predicts how well a patient will respond to chemoprevention combined with targeted therapy. Researchers will analyze tumor tissue and blood samples using advanced techniques like spatial transcri…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Can a simple test predict immunotherapy outcomes for pancreatic cancer?
Knowledge-focused OngoingThis study aims to develop a way to predict which patients with advanced pancreatic cancer will respond to immunotherapy. Researchers will collect tumor tissue, blood, and stool samples from 100 participants before and during treatment. By analyzing these samples, they hope to cr…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC